English (Outside US Only)
正體中文
Having filed the FP-10 application to British NHS, now, Coreleader is going to kick off a series trials in UK to prove the superiority of its Algi-white after a full year preparation.
We have so far worked with leading TVNs of three clinics and two community hospitals which focus more on aged patients with high potential of ulcers. As the FP-10 approval is imminent, the urgency of the trials is escalating. The plan to complete all primary trials within three months will simply supplies more domestic proof to British medical staff of the impressive efficacy of Algi-white over those substandard product from our rivals.
We have so far worked with leading TVNs of three clinics and two community hospitals which focus more on aged patients with high potential of ulcers. As the FP-10 approval is imminent, the urgency of the trials is escalating. The plan to complete all primary trials within three months will simply supplies more domestic proof to British medical staff of the impressive efficacy of Algi-white over those substandard product from our rivals.
See you soon in London.
發表日期:2014-04-21